Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Antidiabetic activity of PPARgamma ligand related to effects on DPP-IV

June 18, 2002

Improvement in glucose tolerance in ZDF rats treated with NVP-DPP-728

June 18, 2002

Pegylated Axokine enters phase I for treatment of obesity

June 18, 2002

MEDICA 16 inhibits hepatic acetyl-CoA carboxylase in insulin-resistant rats

June 18, 2002

DPP-IV inhibitors and their use in diabetes and related disorders reported by Tanabe

June 18, 2002

BMS-298585 exerts both glucose- and lipid-lowering effects in animal models

June 17, 2002

ADA news: dual PPARalpha/gamma agonist has beneficial effects on glucose, lipids

June 17, 2002

HIM2 examined for systemic pharmacokinetics in dogs, oral absorption in diabetic patients

June 17, 2002

Safety data for NBI-6024 in adolescent type 1 diabetics support further development

June 17, 2002

Axokine enters study in obese patients with type 2 diabetes

June 17, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 24, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...
In the clinic for June 22, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Alkermes, Boehringer, Cambrian, F2G, Intrabio, Lexeo, Memo, Novocure,...